August 20, 2019; 93 (8) Corrections
INTREPAD
A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
First published August 19, 2019, DOI: https://doi.org/10.1212/WNL.0000000000007919
INTREPAD
A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
Neurology Aug 2019, 93 (8) 371; DOI: 10.1212/WNL.0000000000007919
Citation Manager Formats
Make Comment
See Comments
See original article:

In the article “INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease" by Meyer et al.,1 first published online April 5, 2019, Dr. Lafaille-Magnan’s name should appear in the author list as Marie-Elyse Lafaille-Magnan. The authors regret the error.
- © 2019 American Academy of Neurology
Reference
- 1.↵
- Meyer PF,
- Tremblay-Mercier J,
- Leoutsakos J, et al.
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement